{"twitch"=>"", "youtube"=>"", "linkedin"=>"", "flickr"=>"", "bio"=>"", "reddit"=>"", "facebook"=>"", "website"=>"", "twitterinfo"=>"", "othersocialmedia"=>"", "instagram"=>""}
Sessions in which Brian G. Ballios, MD, PhD, FRCSC, DABO participates
Saturday 11 June, 2022
Sessions in which Brian G. Ballios, MD, PhD, FRCSC, DABO attends
Saturday 11 June, 2022
Innovation in Retina Research Award Learning ObjectivesAt the end of this symposium, participants will be able to:Identify innovative Canadian retina research proposals and their intended benefitDescribe how using digital innovations in ophthalmology can optimize patie...
Learning ObjectivesAt the end of this session, participants will be able to:Assess and manage vitreoretinal lymphomaDescribe the choroidal changes in the treatment of diabetic retinopathyIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar
Learning Objectives:To review treatment strategies for managing intraocular lens complicationsTo review pearls for performing cataract surgery in patients with corneal conditions.To understand healthcare economics associated with ocular surface disease and cataract surgeryCanMEDS Roles: Medical expert; Scholar
Learning ObjectivesAt the end of this session, participants will be able to:Manage macular edema secondary to retinal vein occlusionDescribe management of peripapillary choroidal melanomasIntegrate new concepts in retinal detachment managementCanMEDS Roles: Medical Expert, Scholar
Learning ObjectivesAt the end of this session, participants will be able to:Define the signs and symptoms of Limbal Stem Cell DeficiencyDescribe the treatment modalities currently in use to treat Limbal Stem Cell DeficiencyDescribe how gene-based therapy is used to treat retinal diseaseDescribe how cell-based therapy is used to treat retinal diseaseCanMEDS Roles: Medical Expert, Professional
Learning ObjectivesAt the end of this session, participants will be able to:Describe prognostication for uveal melanomaApply real word data to the management of macular degeneration, diabetic macular edemaAssess patient experiences of inherited retinal diseasesCanMEDS Roles: Medical Expert, Scholar
Authors: Varun Chaudhary, Jean-François Korobelnik, Paul Mitchell, Se Woong Kang, Ramin Tadayoni, Helmut Allmeier, JinKyung Lee, Tobias Machewitz, Kristian T. Johnson, Clare Bailey. Author Disclosure Block: V. Chaudhary: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Novartis, Bayer. Any direct financial payments including receipt of honoraria; Description of relationship(s); Spe...
Authors: Imaan Z. Kherani1, Chad Andrews2, Jennifer Pereira3, Larissa Moniz4, Cynthia X. Qian5. 1Temerty Faculty of Medicine, University of Toronto, 2College of Optometrists of Ontario, 3JRL Research & Consulting Inc., 4Fighting Blindness Canada, 5Department of Ophthalmology, Universite de Montreal.Author Disclosure Block: I.Z. Kherani: None. C. Andrews: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Fighting Blin...
Authors: Ellen Tianwei Zhou, Pierre-Olivier Kassis, Cynthia Qian, Patrick Hamel, Sylvain Chemtob, Anne-Monique Nuyt, Thuy Mai Luu.Author Disclosure Block: E.T. Zhou: None. P. Kassis: None. C. Qian: None. P. Hamel: None. S. Chemtob: None. A. Nuyt: None. T. Luu: None.Purpose: Retinopathy of prematurity (ROP) remains the dominant cause of severe visual impairment in childhood in North America and Europe. With the improvement in ne...
Sunday 12 June, 2022
LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...
Learning ObjectivesAt the end of this session, participants will be able to:Utilize OCT Imaging to differentiate various types of Pigmented Epithelial DetachmentsUtilize OCT Imaging of the choroid...